Comments
Loading...

Beta Bionics Analyst Ratings

BBNXNASDAQ
Logo brought to you by Benzinga Data
Q1 2025 Earnings were released on Tue May 6th, after the market close
The most recent conference call was at 16:30 PM, 1 day ago Click to view past webcast
Consensus Rating1
Buy
Highest Price Target1
$31.00
Lowest Price Target1
$20.00
Consensus Price Target1
$26.67

Beta Bionics Analyst Ratings and Price Targets | NASDAQ:BBNX | Benzinga

Beta Bionics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Beta Bionics Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
5
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Stifel
Lake Street
Piper Sandler
Leerink Partners
Ladenburg Thalmann

1calculated from analyst ratings

Analyst Ratings for Beta Bionics

Buy NowGet Alert
02/24/2025Buy NowStifel
Mathew Blackman64%
→ $25Initiates → BuyGet Alert
02/24/2025Buy NowLake Street
Brooks O'Neil36%
→ $30Initiates → BuyGet Alert
02/24/2025Buy NowPiper Sandler
Matt O'Brien51%
→ $26Initiates → OverweightGet Alert
02/24/2025Buy NowLeerink Partners
Mike Kratky66%
→ $28Initiates → OutperformGet Alert
02/20/2025Buy NowLadenburg Thalmann
Jeff Cohen59%
→ $31Initiates → BuyGet Alert
02/20/2025Buy NowBaird
Jeff Johnson77%
→ $20Initiates → NeutralGet Alert

FAQ

Q

What is the target price for Beta Bionics (BBNX) stock?

A

The latest price target for Beta Bionics (NASDAQ:BBNX) was reported by Stifel on February 24, 2025. The analyst firm set a price target for $25.00 expecting BBNX to rise to within 12 months (a possible 89.97% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Beta Bionics (BBNX)?

A

The latest analyst rating for Beta Bionics (NASDAQ:BBNX) was provided by Stifel, and Beta Bionics initiated their buy rating.

Q

When was the last upgrade for Beta Bionics (BBNX)?

A

There is no last upgrade for Beta Bionics

Q

When was the last downgrade for Beta Bionics (BBNX)?

A

There is no last downgrade for Beta Bionics.

Q

When is the next analyst rating going to be posted or updated for Beta Bionics (BBNX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Beta Bionics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Beta Bionics was filed on February 24, 2025 so you should expect the next rating to be made available sometime around February 24, 2026.

Q

Is the Analyst Rating Beta Bionics (BBNX) correct?

A

While ratings are subjective and will change, the latest Beta Bionics (BBNX) rating was a initiated with a price target of $0.00 to $25.00. The current price Beta Bionics (BBNX) is trading at is $13.16, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch